Cure Pharmaceutical Holding Corp. (CURR)
NASDAQ · Technology
Cure Pharmaceutical Holding Corp. Operating Income 2023–2024
Cure Pharmaceutical Holding Corp. annual/quarterly operating income history and growth rate from 2023 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Cure Pharmaceutical Holding Corp. operating income for the quarter ending March 31, 2025 was -4.3 M, a 204.15% increase year-over-year.
- Cure Pharmaceutical Holding Corp. operating income for the twelve months ending March 31, 2025 was -24.0 M.
- Cure Pharmaceutical Holding Corp. annual operating income for 2024 was -27.4 M, a 311.93% increase from 2023.
- Cure Pharmaceutical Holding Corp. annual operating income for 2023 was -6.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cure Pharmaceutical Holding Corp. Operating Income — FAQ
Cure Pharmaceutical Holding Corp. (CURR) operating income over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Cure Pharmaceutical Holding Corp.'s operating income?
Cure Pharmaceutical Holding Corp. (CURR) reported operating income of -$27M for fiscal 2024.
Where can I see CURR's operating income history?
The chart and table above show Cure Pharmaceutical Holding Corp.'s operating income by year and by quarter, including the growth rate.